πŸ‡ΊπŸ‡Έ FDA
Patent

US 9029388

Condensed heterocyclic compound

granted A61PA61P25/18A61P43/00

Quick answer

US patent 9029388 (Condensed heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P25/18, A61P43/00